Distance as an Obstacle to Clinical Trial Access: Who Is Affected and Why It Matters
Link
Additional link
Description
Evaluates factors associated with geographic remoteness of 60 miles or more from the nearest phase 2 or 3 clinical trial for a variety of health conditions. Discusses American Indian reservations and rural areas, and provides data on demographic factors associated with remoteness including race and ethnicity, educational attainment, and poverty. Includes a county-level interactive map of clinical trial remoteness for health conditions including cancers, substance use disorder, diabetes, obesity, COPD, stroke, and more.
Author(s)
Andrew Friedson, Bumyang Kim, Maggie Switek, Lawson Mansell
Date
06/2024
Type
Document
Organization
The Milken Institute
Tagged as
Access · American Indian or Alaska Native · Arthritis · COVID-19 · Cancer · Cardiovascular disease · Chronic respiratory conditions · County-by-county data · Dementia · Diabetes · Educational attainment · HIV and AIDS · Infectious diseases · Mental health conditions · Obesity and weight control · Poverty · Racial and ethnic groups · Rural-urban differences · Statistics and data · Substance use and misuse